{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T13:19:24Z","timestamp":1753881564301,"version":"3.41.2"},"reference-count":49,"publisher":"American Society for Microbiology","issue":"8","license":[{"start":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T00:00:00Z","timestamp":1626393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1128\/ASMCopyrightv2"},{"start":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T00:00:00Z","timestamp":1626393600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2021,7,16]]},"abstract":"<jats:p>Antitoxin is currently the only approved therapy for botulinum intoxications. The efficacy of antitoxin preparations is evaluated in animals. However, while in practice antitoxin is administered to patients only after symptom onset, in most animal studies, it is tested in relation to time postintoxication.<\/jats:p>","DOI":"10.1128\/aac.00421-21","type":"journal-article","created":{"date-parts":[[2021,5,10]],"date-time":"2021-05-10T12:44:13Z","timestamp":1620650653000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":5,"title":["A Novel Running Wheel Mouse Model for Botulism and Its Use for the Evaluation of Postsymptom Antitoxin Efficacy"],"prefix":"10.1128","volume":"65","author":[{"given":"Arieh","family":"Schwartz","sequence":"first","affiliation":[{"name":"Department of Biotechnology, Israel Institute for Biological Research, Ness Ziona, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alon","family":"Ben David","sequence":"additional","affiliation":[{"name":"Department of Biotechnology, Israel Institute for Biological Research, Ness Ziona, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mordechai","family":"Hotoveli","sequence":"additional","affiliation":[{"name":"Department of Environmental Physics, Israel Institute for Biological Research, Ness Ziona, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eyal","family":"Dor","sequence":"additional","affiliation":[{"name":"Department of Biotechnology, Israel Institute for Biological Research, Ness Ziona, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eran","family":"Diamant","sequence":"additional","affiliation":[{"name":"Department of Biotechnology, Israel Institute for Biological Research, Ness Ziona, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arik","family":"Vivyorka","sequence":"additional","affiliation":[{"name":"Division of Operations &amp; Infrastructure, Israel Institute for Biological Research, Ness Ziona, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osnat","family":"Rosen","sequence":"additional","affiliation":[{"name":"Department of Biotechnology, Israel Institute for Biological Research, Ness Ziona, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amram","family":"Torgeman","sequence":"additional","affiliation":[{"name":"Department of Biotechnology, Israel Institute for Biological Research, Ness Ziona, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3249-4901","authenticated-orcid":true,"given":"Ran","family":"Zichel","sequence":"additional","affiliation":[{"name":"Department of Biotechnology, Israel Institute for Biological Research, Ness Ziona, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.8.1059"},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1124\/pr.116.012658"},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.1097\/DMP.0b013e318158c5fd"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1128\/MR.44.3.419-448.1980"},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1086\/508176"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/167.2.451"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6429a6"},{"key":"e_1_3_1_9_2","unstructured":"Centers for Disease Control and Prevention. 2018. Bioterrorism agents\/diseases. https:\/\/emergency.cdc.gov\/agent\/agentlist-category.asp."},{"key":"e_1_3_1_10_2","volume-title":"Botulism antitoxin.","author":"Ni SA","year":"2021","unstructured":"Ni SA, Brady MF. 2021. Botulism antitoxin. StatPearls, Treasure Island, FL."},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa051926"},{"key":"e_1_3_1_12_2","doi-asserted-by":"publisher","DOI":"10.1086\/444507"},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4757-9542-4_52"},{"key":"e_1_3_1_14_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02121011"},{"key":"e_1_3_1_15_2","first-page":"344","article-title":"Experimental studies on the serum therapy of type E botulism: the relationship between the amount of toxin in the blood and the effect of antitoxic serum","volume":"23","author":"Iida H","year":"1970","unstructured":"Iida H, Ono T, Karashimada T. 1970. Experimental studies on the serum therapy of type E botulism: the relationship between the amount of toxin in the blood and the effect of antitoxic serum. Jpn J Med Sci Biol 23:344\u2013347.","journal-title":"Jpn J Med Sci Biol"},{"key":"e_1_3_1_16_2","first-page":"282","article-title":"Studies on the serum therapy of type E botulism: absorption of toxin from the gastrointestinal tract","volume":"23","author":"Iida H","year":"1970","unstructured":"Iida H, Ono T, Karashimada T, Ando Y. 1970. Studies on the serum therapy of type E botulism: absorption of toxin from the gastrointestinal tract. Jpn J Med Sci Biol 23:282\u2013285.","journal-title":"Jpn J Med Sci Biol"},{"key":"e_1_3_1_17_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/120.5.534"},{"key":"e_1_3_1_18_2","doi-asserted-by":"publisher","DOI":"10.7883\/yoken1952.23.177"},{"key":"e_1_3_1_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/0041-0101(79)90103-X"},{"key":"e_1_3_1_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxicon.2015.11.010"},{"key":"e_1_3_1_21_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0222670"},{"key":"e_1_3_1_22_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02379-17"},{"key":"e_1_3_1_23_2","doi-asserted-by":"publisher","DOI":"10.1242\/dmm.035089"},{"key":"e_1_3_1_24_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix815"},{"key":"e_1_3_1_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.446"},{"key":"e_1_3_1_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxicon.2015.06.021"},{"key":"e_1_3_1_27_2","doi-asserted-by":"publisher","DOI":"10.1002\/mus.22210"},{"key":"e_1_3_1_28_2","doi-asserted-by":"publisher","DOI":"10.1098\/rspb.2014.0210"},{"key":"e_1_3_1_29_2","doi-asserted-by":"publisher","DOI":"10.1152\/japplphysiol.00880.2017"},{"key":"e_1_3_1_30_2","unstructured":"Mimran A Chay Y Barnea A Halperin G Reuveny S Zichel R. 2012. Evaluating the efficacy of post-clinical symptom anti-toxin therapy in a mouse model of botulism A and B. Presented at the 49th Interagency Botulism Research Coordinating Committee Meeting (IBRCC) Baltimore MD."},{"key":"e_1_3_1_31_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/166.6.1281"},{"key":"e_1_3_1_32_2","doi-asserted-by":"publisher","DOI":"10.2174\/1568026616666160413135630"},{"key":"e_1_3_1_33_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1008302107"},{"key":"e_1_3_1_34_2","doi-asserted-by":"publisher","DOI":"10.1021\/acs.accounts.9b00261"},{"key":"e_1_3_1_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2005.12.029"},{"key":"e_1_3_1_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2016.06.001"},{"key":"e_1_3_1_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuro.2016.12.008"},{"key":"e_1_3_1_38_2","first-page":"310","article-title":"Potency test and therapeutic effect of type E botulinus antitoxin","volume":"16","author":"Kondo H","year":"1963","unstructured":"Kondo H, Kondo S, Murata R, Sakaguchi G. 1963. Potency test and therapeutic effect of type E botulinus antitoxin. Jpn J Med Sci Biol 16:310\u2013311.","journal-title":"Jpn J Med Sci Biol"},{"key":"e_1_3_1_39_2","first-page":"311","article-title":"Specific antitoxin therapy in type E botulism","volume":"16","author":"Iida H","year":"1963","unstructured":"Iida H. 1963. Specific antitoxin therapy in type E botulism. Jpn J Med Sci Biol 16:311\u2013313.","journal-title":"Jpn J Med Sci Biol"},{"key":"e_1_3_1_40_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0090252"},{"key":"e_1_3_1_41_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro3295"},{"key":"e_1_3_1_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxicon.2012.11.011"},{"key":"e_1_3_1_43_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-129-3-199808010-00011"},{"key":"e_1_3_1_44_2","doi-asserted-by":"publisher","DOI":"10.2174\/1568026615666150309150338"},{"key":"e_1_3_1_45_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0085517"},{"key":"e_1_3_1_46_2","doi-asserted-by":"publisher","DOI":"10.1128\/JB.72.4.455-460.1956"},{"key":"e_1_3_1_47_2","first-page":"574","article-title":"On an approximate method of determining the median effective dose and its error, in the case of a quantal response","volume":"39","author":"Irwin JO","year":"1939","unstructured":"Irwin JO, Cheeseman EA. 1939. On an approximate method of determining the median effective dose and its error, in the case of a quantal response. J Hyg (Lond) 39:574\u2013580.","journal-title":"J Hyg (Lond"},{"key":"e_1_3_1_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biologicals.2017.06.003"},{"key":"e_1_3_1_49_2","first-page":"1029","volume-title":"European pharmacopoeia","author":"European Directorate for the Quality of Medicines and Healthcare","year":"2014","unstructured":"European Directorate for the Quality of Medicines and Healthcare. 2014. European pharmacopoeia, 8th ed, vol 1, p 1029. EDQM Council of Europe, Strasbourg, France.","edition":"8"},{"key":"e_1_3_1_50_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0209019"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.00421-21","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.00421-21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T23:00:45Z","timestamp":1645484445000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.00421-21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,16]]},"references-count":49,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,7,16]]}},"alternative-id":["10.1128\/AAC.00421-21"],"URL":"https:\/\/doi.org\/10.1128\/aac.00421-21","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"type":"print","value":"0066-4804"},{"type":"electronic","value":"1098-6596"}],"subject":[],"published":{"date-parts":[[2021,7,16]]},"assertion":[{"value":"2021-03-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-05-01","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-07-16","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e00421-21"}}